The new frontier of drug delivery through nanotechnology

Abstract

Nanomedicine is a promising platform for drug delivery systems, offering enhanced therapeutic outcomes and reduced side effects. Nanomicelles are a class of nanoparticles that have shown great potential in delivering a wide range of therapeutics, including small molecules, proteins, and nucleic acids, to treat varied diseases and investigations. This review summarises the current state of the art in nanomedicine and its potential applications in drug delivery system. The use of Nanomicelles in topical medication delivery systems can help minimized side effects and improve patient compliance due to their improved stability and prolonged drug release capabilities. The development of stimuli-responsive micelles that can release drugs at specific conditions within the tumour microenvironment and targeted delivery strategies to enhance specificity and efficiency of gene therapy has shown promising results in terms of improved therapeutic efficacy and therapeutic efficiency. However, the presence of multidrug resistance pumps in brain cells can pose challenges in overcoming MDR mechanisms for certain drugs. These innovative approaches hold promise for enhancing the effectiveness of cancer chemotherapy in the brain and improving the prognosis for patients with brain tumours.